Orthobiologics in anterior cruciate ligament (ACL) reconstruction: A narrative review
Por:
Ostojic, M, Ragni, E, Lovrekovic, B, Valcarenghi, J, Dzidzishvili, L, Ramadanov, N, Salzmann, M, Rotim, C, Prill, R, Sabalic, S, Becker, R and Indelli, PF
Publicada:
17 mar 2026
Ahead of Print:
1 mar 2026
Resumen:
Anterior cruciate ligament (ACL) injury is one of the most frequent injuries in sports medicine. Despite advancements in surgical techniques, suboptimal results in terms of delayed graft incorporation into bone tunnels and ligamentization, as well as inferior clinical outcomes, still present significant challenges in treating these injuries. Orthobiological modalities such as platelet-rich plasma (PRP) and stem cells have emerged as a potential adjunct to ACL treatment, with a theoretical advantage in enhancing local biological processes and subsequent improvements in clinical outcomes. Embase, Cochrane, and PubMed databases were searched for relevant literature. The aim of this narrative review was to summarize the currently available evidence on the efficacy of orthobiologics, or the lack thereof, in ACL repair and reconstruction (ACLR), with emphasis on graft incorporation into bone tunnels, ligamentization, and overall clinical outcomes. These modalities exert their theoretical effect by delivering growth factors, anti-inflammatory cytokines, and regenerative cells to the target site, which enhance local biological processes. Although some research has shown positive effects of orthobiologics in ACLR, clinical outcomes remain inconsistent, without consensus on preparation methods and administration protocols. The lack of homogeneous, high-quality methodology in existing studies limits the possibility of drawing definitive conclusions on the efficacy of orthobiologics in ACLR. Although orthobiological modalities provide theoretical benefits in improving outcomes, until more robust evidence is available regarding their efficacy and optimal application methods, their routine use warrants caution and cannot yet be recommended. Future research should focus on improving and standardizing clinical and research protocols before drawing any definitive conclusions on this matter.
Filiaciones:
Ostojic, M:
Univ Hosp Sisters Mercy, Traumatol Dept Dragkoviceva, Sports Traumatol Div, Zagreb, Croatia
Osteon Orthoped & Sports Med Clin, Mostar, Bosnia & Herceg
Ragni, E:
IRCCS Osped Galeazzi St Amborgio, Orthoped Biotechnol Lab, Milan, Italy
Lovrekovic, B:
Univ Hosp Merkur, Dept Gen & Sports Traumatol & Orthoped, Zagreb, Croatia
Univ Zagreb, Fac Kinesiol, Zagreb, Croatia
Valcarenghi, J:
Univ Hosp Ctr Site Kennedy, CHU Helora, Dept Orthoped Surg & Traumatol, Mons, Belgium
:
Autonomous Univ Barcelona, Germans Trias Univ Hosp, Dept Orthoped, Barcelona, Spain
Ramadanov, N:
Univ Hosp Brandenburg Havel, Brandenburg Med Sch, Ctr Orthoped & Traumatol, Brandenburg, Germany
Salzmann, M:
Univ Hosp Brandenburg Havel, Brandenburg Med Sch, Ctr Orthoped & Traumatol, Brandenburg, Germany
Brandenburg Med Sch Theodor Fontane, Fac Hlth Sci, Brandenburg, Germany
Rotim, C:
Univ Hosp Sisters Mercy, Traumatol Dept Dragkoviceva, Sports Traumatol Div, Zagreb, Croatia
Josip Juraj Strossmayer Univ Osijek, Fac Dent Med & Hlth, Osijek, Croatia
Prill, R:
Univ Hosp Brandenburg Havel, Brandenburg Med Sch, Ctr Orthoped & Traumatol, Brandenburg, Germany
Sabalic, S:
Univ Hosp Sisters Mercy, Traumatol Dept Dragkoviceva, Sports Traumatol Div, Zagreb, Croatia
Univ Hosp Sisters Mercy, Traumatol Dept Dragkoviceva, Geriatr Traumatol & Hip Surg Div, Zagreb, Croatia
Becker, R:
Univ Hosp Brandenburg Havel, Brandenburg Med Sch, Ctr Orthoped & Traumatol, Brandenburg, Germany
Indelli, PF:
Univ Hosp Sisters Mercy, Traumatol Dept Dragkoviceva, Sports Traumatol Div, Zagreb, Croatia
Osteon Orthoped & Sports Med Clin, Mostar, Bosnia & Herceg
IRCCS Osped Galeazzi St Amborgio, Orthoped Biotechnol Lab, Milan, Italy
South Tyrol Healthcare Syst, Brixen, Italy
Paracelsus Med Univ, Inst Biomech, Salzburg, Austria
gold
|